Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
11 results
  • Bone Marrow Transplant

22-171          Phase I

A Phase 1b Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of SER-155 in Adults Undergoing Hematopoietic Stem Cell Transplantation to Reduce the Risk of Infection and Graft vs. Host Disease (View details on clinicaltrial.gov)

  • Bone Marrow Transplant

18-499          Phase II

A Phase 2, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of KD025 in Subjects with Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy (The ROCKstar Study) (View details on clinicaltrial.gov)

  • Bone Marrow Transplant

22-229          Phase III

A Phase 3 Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of AB-205 plus Standard of Care versus Placebo plus Standard of Care in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) (E-CELERATE) (View details on clinicaltrial.gov)

  • Bone Marrow Transplant

22-387          Phase III

A Phase Ib /Randomized Phase III Trial of Patients with Advanced Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation with Either Orca-T, a T-cell-Depleted Graft with Additional Infusion of Conventional T cells and Regulatory T cells, or Standard-of-Care Allogeneic Graft (View details on clinicaltrial.gov)

  • Bone Marrow Transplant

21-214          Phase I

A Phase Ib Study of oral decitabine/cedazuridine as maintenance therapy following allogeneic hematopoietic cell transplantation for patients with myeloid neoplasms (View details on clinicaltrial.gov)

  • Bone Marrow Transplant, Myelodysplastic Syndromes

17-569          Phase II

A Phase II Study of Ruxolitinib Pre-, During- and Post-Hematopoietic Stem Cell Transplantation for Patients With Primary or Secondary Myelofibrosis (View details on clinicaltrial.gov)

  • Bone Marrow Transplant

22-014          Phase II

A randomized, double-blind trial to evaluate the safety and efficacy of apraglutide in subjects with Grade II to IV (MAGIC) steroid refractory gastrointestinal (GI) acute graft versus host disease on best available therapy (View details on clinicaltrial.gov)

  • Bone Marrow Transplant

20-049          Phase III

A Randomized, Open Label Phase 3 Study Evaluating Safety and Efficacy of Venetoclax in combination with Azacitidine after allogeneic Stem Cell Transplantation in Subjects with Acute Myeloid Leukemia (AML) (VIALE-T) (View details on clinicaltrial.gov)

  • Bone Marrow Transplant

20-706          Phase II

AGAVE-201, A Phase 2, Open-label, Randomized, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Axatilimab at 3 Different Doses in Patients with Recurrent or Refractory Active Chronic Graft Versus Host Disease who have Received at least 2 Lines of Systemic Therapy (View details on clinicaltrial.gov)

  • Bone Marrow Transplant

19-336          N/A

Reduced intensity haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide and sirolimus/mycophenolate mofetil/RGI-2001 based GVHD prevention: a pilot study (View details on clinicaltrial.gov)

Showing 1 - 10 of 11 results